|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Moria S.A. Release: Epi-K Approved For Sale In USA, Europe, And Japan
10/19/2005 5:13:10 PM
ANTONY, France & DOYLESTOWN, Pa.--(BUSINESS WIRE)--March 30, 2005--Moria announced today that the Epi-K(TM), its disposable epikeratome for Epi-LASIK, has received FDA approval for marketing in the United States. The device has also recently received a CE Mark authorizing sales in the European Community and has been approved for sale in Japan.
The Epi-K(TM) is utilized to mechanically separate the epithelium from Bowman's membrane. The epithelial flap is then folded back prior to laser ablation, and subsequently returned to its original position. The procedure preserves the structural integrity of the stroma and is expected to minimize discomfort, shorten the length of visual recovery, and reduce the incidence of haze associated with other surface ablation procedures, such as PRK and LASEK.
|
|
|
|
|
|
|
|
|
|
|